Further metabolic pathway enrichment analysis indicated that MY mainly affected basal cell carcinoma, the intestinal immune network for IgA production, steroid hormone biosynthesis, vitamin digestion and absorption, serotonergic synapses, arachidonic acid metabolism, and ovarian steroidogenesis (Figure 4C). This evidence concerns the gene CD79A and basal cell carcinoma.